Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/17/21
Charles River Laboratories (CRL) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/17/21
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 GuidanceBusiness Wire • 02/17/21
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy DevelopmentBusiness Wire • 02/17/21
Algernon Pharmaceuticals inks deal with Charles River Laboratories for preclinical work on DMT for strokeProactive Investors • 02/08/21
Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug ScreeningBusiness Wire • 01/28/21
Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference CallBusiness Wire • 01/20/21
Charles River Laboratories International (CRL) CEO James Foster on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/31/20
Charles River Laboratories International, Inc.'s (CRL) CEO James Foster On Q3 2020 Results - Quick Version Earnings Call TranscriptSeeking Alpha • 10/29/20
Were Hedge Funds Right About Crowding Into Charles River Laboratories (CRL)?Insider Monkey • 10/27/20
Charles River Laboratories Schedules Third-Quarter 2020 Earnings Release and Conference CallBusiness Wire • 10/13/20